» Articles » PMID: 35408840

A New Target of Dental Pulp-Derived Stem Cell-Based Therapy on Recipient Bone Marrow Niche in Systemic Lupus Erythematosus

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Apr 12
PMID 35408840
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances in mesenchymal stem/stromal cell (MSC) research have led us to consider the feasibility of MSC-based therapy for various diseases. Human dental pulp-derived MSCs (hDPSCs) have been identified in the dental pulp tissue of deciduous and permanent teeth, and they exhibit properties with self-renewal and in vitro multipotency. Interestingly, hDPSCs exhibit superior immunosuppressive functions toward immune cells, especially T lymphocytes, both in vitro and in vivo. Recently, hDPSCs have been shown to have potent immunomodulatory functions in treating systemic lupus erythematosus (SLE) in the SLE MRL/ mouse model. However, the mechanisms underlying the immunosuppressive efficacy of hDPSCs remain unknown. This review aims to introduce a new target of hDPSC-based therapy on the recipient niche function in SLE.

Citing Articles

The Role of Dental-derived Stem Cell-based Therapy and Their Derived Extracellular Vesicles in Post-COVID-19 Syndrome-induced Tissue Damage.

Rostami M, Farahani P, Esmaelian S, Bahman Z, Hussein A, A Alrikabi H Stem Cell Rev Rep. 2024; 20(8):2062-2103.

PMID: 39150646 DOI: 10.1007/s12015-024-10770-y.


Modeling Lysosomal Storage Disorders in an Innovative Way: Establishment and Characterization of Stem Cell Lines from Human Exfoliated Deciduous Teeth of Mucopolysaccharidosis Type II Patients.

Carvalho S, Santos J, Moreira L, Duarte A, Gaspar P, Rocha H Int J Mol Sci. 2024; 25(6).

PMID: 38542525 PMC: 10970756. DOI: 10.3390/ijms25063546.


Immunomodulatory Mechanism and Potential Application of Dental Pulp-Derived Stem Cells in Immune-Mediated Diseases.

Min Q, Yang L, Tian H, Tang L, Xiao Z, Shen J Int J Mol Sci. 2023; 24(9).

PMID: 37175774 PMC: 10178746. DOI: 10.3390/ijms24098068.


Extracellular vesicles rejuvenate the microenvironmental modulating function of recipient tissue-specific mesenchymal stem cells in osteopenia treatment.

Sonoda S, Yamaza T Front Endocrinol (Lausanne). 2023; 14:1151429.

PMID: 37033255 PMC: 10073676. DOI: 10.3389/fendo.2023.1151429.


Dental pulp stem cells induce anti-inflammatory phenotypic transformation of macrophages to enhance osteogenic potential via IL-6/GP130/STAT3 signaling.

Liu B, Li J, Chen B, Shuai Y, He X, Liu K Ann Transl Med. 2023; 11(2):90.

PMID: 36819570 PMC: 9929758. DOI: 10.21037/atm-22-6390.


References
1.
Ozdemir A, Ozgul Ozdemir R, Kirmaz C, Eker Sariboyaci A, Unal Halbutogllari Z, Ozel C . The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets. Cell Immunol. 2016; 310:108-115. DOI: 10.1016/j.cellimm.2016.08.008. View

2.
Noxon V, Knopf K, Norris L, Chen B, Yang Y, Qureshi Z . Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia. J Oncol Pract. 2017; 13(6):e562-e573. PMC: 6366245. DOI: 10.1200/JOP.2016.019364. View

3.
Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, Chirumbolo G . Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation. 2005; 80(6):836-42. DOI: 10.1097/01.tp.0000173794.72151.88. View

4.
Wobma H, Satwani P . Mesenchymal stromal cells: Getting ready for clinical primetime. Transfus Apher Sci. 2021; 60(1):103058. DOI: 10.1016/j.transci.2021.103058. View

5.
Pittenger M, Discher D, Peault B, Phinney D, Hare J, Caplan A . Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019; 4:22. PMC: 6889290. DOI: 10.1038/s41536-019-0083-6. View